A population-based audit of ethnicity and breast cancer risk in one general practice catchment area in North London, UK: Implications for practice

Hereditary Cancer in Clinical Practice

Volumn 5, Issue 3, 2007, Pages 157-160

  Ferris, Michelle ^a   Easton, Douglas F ^b   Doherty, Rebecca J ^c   Briggs, Brian H J ^a   Newman, Michelle ^a   Saraf, Ifrhikhar M ^a   Scambler, Sarah ^a   Wagman, Lyndon ^a   Wyndham, Michael T ^a   Ward, Ann ^c   Eeles, Rosalind A ^c,d  

^a Lane End Medical Group   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^d INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Ashkenazi; Breast cancer risk

Indexed keywords

TAMOXIFEN;

ADOLESCENT; ADULT; AGED; ARTICLE; BREAST CANCER; BREAST FEEDING; CANCER INCIDENCE; CANCER RISK; CLINICAL PRACTICE; CONTROLLED STUDY; ETHNICITY; FEMALE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL CONTRACEPTION; QUESTIONNAIRE; UNITED KINGDOM;

EID: 35348917165     PISSN: 17312302     EISSN: None     Source Type: Journal    
DOI: 10.1186/1897-4287-5-3-157     Document Type: Article

References (8)

1. Struewing JP, Abeliovich D, Peretz T, Avishai N, Kaback MM, Collins FS, Brody LC. The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nat Genet 1995; 11: 198-200.
2. Oddoux C, Struewing JP, Clayton CM, Neuhausen S, Brody LC, Kaback M, Haas B, Norton L, Borgen P, Jhanwar S, Goldgar D, Ostrer H, Offit K. The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%. Nat Genet 1996; 14: 188-190.
3. Roa BB, Boyd AA, Volcik K, Richards CS. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nat Genet 1996; 14: 185-187.
4. Newill VA. Distribution of cancer mortality among ethnic subgroups of the white population of New York City, 1953-1958. J Natl Cancer Inst 1961; 26: 405-417.
5. Egan KM, Newcomb PA, Longnecker MP, Trentham-Dietz A, Baron JA, Trichopoulos D, Stampfer MJ, Willett WC. Jewish religion and risk of breast cancer. Lancet 1996; 347: 1645-1646.
6. Feldman GE. Do Ashkenazi Jews have a higher than expected cancer burden? Implications for cancer control prioritization efforts. Isr Med Assoc J 2001; 3: 341-346.
7. Althuis MD, Dozier JM, Anderson WF, Devesa SS, Brinton LA. Global trends in breast cancer incidence and mortality 1973-1997. Int J Epidemiol 2005; 34: 405-412.
8. www.nice.org.uk.